In patients with cardiomyopathies accurate elimination of the substrate for ventricular tachycardias is crucial. This is commonly performed by radiofrequency catheter ablation. In cardiomyopathy subtypes the substrate may be difficult to reach by conventional endo- or epicardial approaches. Over the last years WECAM’s physicians and researchers have developed and applied new strategies.
Radiofrequency catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy can be challenging. Stereotactic body radiotherapy is an emerging technique for these difficult ablations requiring precise substrate delineation and data transfer. Based on our longstanding experience with multimodal data integration we have developed, together with international partners, a highly accurate workflow with promising clinical results.
Surgical arrhythmia treatment
Within WECAM an established multidisciplinary team provides hybrid treatment for ventricular arrhythmias. For this purpose a hybrid operation room equipped with state of the art mapping and ablation facilities has recently been built. The systematic evaluation of hybrid procedures are the basis for novel approaches.
Novel technologies and energy sources to increase lesion size and reach VT substrates are under investigation.